|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Immediate monthly combination contraception to facilitate initiation of the |
| depot medroxyprogesterone acetate contraceptive injection. |
| Morroni C; Grams M; Tiezzi L; Westhoff C |
| Contraception. 2004 Jul;70(1):19-23. |
| Conventional clinical protocols specify that women initiate depot medroxy progesterone acetate (DMPA) within 7 days |
| of the onset of menses, and product labeling specifies initiation within 5 days. Women outside of this window |
| should wait until next menses to begin, often leaving them with inadequate interim contraceptive protection. An |
| alternative is for women to initiate monthly hormonal contraception immediately, as a bridge to DMPA, with a |
| scheduled follow-up appointment about 4 weeks later. We evaluated bridge preferences and DMPA initiation among |
| 150 women requesting DMPA who were ineligible for their first injection at the time of clinic visit due to menstrual |
| cycle day. Ninety-eight percent (n = 147) rejected the standard protocol of waiting with condoms or abstinence in |
| favor of a hormonal bridge method. Ninety-seven percent follow-up (n = 146) showed that 86% were satisfied with their |
| bridge method. There were no post treatment pregnancies, and 55% (n = 81) of participants had initiated DMPA or |
| another long-term contraceptive within 4 weeks of their initial clinic presentation. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Immediate monthly combination contraception to facilitate |
| initiation of the depot medroxyprogesterone acetate contraceptive injection.", is(are) Morroni C; Grams M; Tiezzi L; |
| Westhoff C. The source of this article is "Contraception. 2004 Jul;70(1):19-23.". This article was published in 2004 in |
| English language(s). (PubHealth.info® Document ID: CONT1T 569-06. All rights reserved with PubHealth.info) PIN: |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |